Financials
- Market Capitalization 1.83 B
- Employee 110
- Founded 2024
- CEO N/A
- Website www.inhibrx.com
- Headquarter Delaware, United States
- FIGI BBG01MS5Q9G3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-10.67
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2032 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.30 USD | -4.45% | -17.51% | +10.61% | +211.97% | 1.90 B USD | ||
| 2040 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.70 USD | +0.18% | -7.32% | -3.23% | +100.70% | 1.86 B USD | ||
| 2060 | SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 20.10 USD | +4.20% | +0.90% | +5.73% | +24.69% | 1.79 B USD | ||
| 2067 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.33 USD | -2.06% | -4.86% | +9.90% | -29.15% | 1.78 B USD |